北京招聘

Principle Scientist - JD

Technical Skill Requirements - Specific experience would include but not be limited to:

· Advanced knowledge and experience in oncology drug discovery and/or translational research for small molecule or antibody-based therapeutics.

· Expertise in target validation studies essential using CRISPR or related methodologies: KD/KO/KI of novel genes in transient and stable cell line systems.

· Expertise in developing biochemical assays, cellular functional assays and in vivo efficacy and PD models, again with crucial experience in oncology.

• Extensive experience in molecular biology, pharmacology and cell biology techniques.

General Requirements

· Highly motivated self-starter, able to excel within a matrix organization.

· Highly aware of recent oncology literature and emerging trends and drugs in the oncology area.

• Strong oral and written communication skills, fluent in English and Chinese.
• Critical thinker with good time management and delivery focus, able to independently design, execute and accurately interpret complex scientific experiments and data.
• Excellent people and project manager; skilled in communicating objectives, motivating, empowering and developing junior staff with a track record of successful teamwork and coaching aligned with project delivery.
• Easily able to influence across disciplines and research areas; leveraging both local and global talent and resources to achieve delivery goals.

Key Responsibilities

• Proposal and implementation of strategies to identify, filter and validate novel drug targets for local/global proposal
• Management of novel drug discovery projects up to and including NME declaration with advanced networking and global collaboration skills.
• Leadership of high-performance project teams and direct supervision/coaching of junior staff
• Networking, identification and leadership of academic collaborations to support internal discovery efforts.
• Setup and management of CRO contracts to enable/supplement internal discovery projects.

强生是全球具综合性、业务分布范围广的医疗保健企业，业务涉及消费品、制药、医疗器材三大领域，1985年在华创立了***家合资企业。强生遵循企业信条的价值观，致力于践行“关爱全世界,关注每个人”的健康愿景，以领先的科技研发创造创新的理念、产品和服务，为改善人类健康和福祉而不懈努力。每天，强生遍布世界各地的员工，与他们的合作方一起，为全球消费者和病患带来更健康、更快乐、更长寿的生活。
强生于1985年在华创立了***家合资企业。 多年来，强生不断发挥行业领军作用，以创新、高质量的产品和服务，为中国亿万家庭带来健康。如今，强生在中国的业务涉及消费品、制药、医疗器材三大领域，在北京、上海、广州、苏州、西安等90多个城市，拥有员工总数近10,000人。强生在西安高新技术产业开发区投资兴建先进的大型生产基地，以更好地服务中国和亚太地区其他国家。
强生是***在中国成功实现“端到端”研发模式的跨国企业；并通过实现从早期研发到临床应用，致力于加速中国创新产品的研发，促进中国创新型经济的发展。强生的三大业务领域在中国均设有研发机构, 并在上海建立了强生亚太创新中心，将源自于中国和亚太区域的创新成果推向国际市场。
该创新中心是强生深化外部合作战略的主要窗口。强生将密切与创新企业、学术和科研机构，以及优秀人才的合作，通过提供资金、专业知识和技术，共同将雏形创新转化为医学临床应用的成果，强生并在中国建立全球肺癌研究中心，以满足中国及国际市场的需求，造福病患。
强生心系中国的发展和进步，致力于成为优秀的企业公民。强生积极参与各类重大活动，助力中国的社会经济发展， 并荣幸的成为2008年北京奥运会及残奥会和2010年上海世博会美国馆的全球合作伙伴。
为加强对中国市场的承诺，强生于近期部署了中国发展新战略。强生将融汇全球的资源、凝聚在华的核心业务能力，更加稳健的迈开公司积极创新、完美执行和锐意领先的步伐，为中国创造更多价值。
强生多次荣获《巴伦周刊》“全球最受尊敬企业”的荣誉，充分体现了强生始终以实际行动改善人类健康福祉的不变理念。
2017年，强生连续第33年入选美国《财富》杂志发布的全球最受赞赏企业排行榜，位列总榜第13名，居全球制药行业榜首。